Who is sponsoring NCT03885531?

NCT03885531 is sponsored by Smith & Nephew, Inc..

What drugs are being tested in NCT03885531?

Interventions in NCT03885531: Total knee arthroplasty with Journey II CR Total Knee System.

What condition does NCT03885531 study?

NCT03885531 studies Journey II CR Total Knee System.

Is NCT03885531 still recruiting?

NCT03885531 is currently completed. Last updated 3 January 2024.

Last reviewed 2024-01-03 · How we verify

NCT03885531: JIICR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)

Completed Last updated 3 January 2024

What this trial tests

trial testing Total knee arthroplasty with Journey II CR Total Knee System in Journey II CR Total Knee System in 586 participants. Completed in 30 June 2020.

Timeline

27 March 2019

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Smith & Nephew, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	586
Start date	27 March 2019
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	6 locations across United States

Drugs / interventions tested

Total knee arthroplasty with Journey II CR Total Knee System

Conditions studied

Journey II CR Total Knee System — all drugs for Journey II CR Total Knee System →

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

Eligibility, any sex, with Journey II CR Total Knee System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

NCT07025304 — Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate · NA · recruiting
NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03885531 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
Last refreshed: 3 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03885531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing